Immunization has the power to save millions of lives, but complete immunization coverage can only be achieved by strengthening systems that deliver life-saving vaccines. ITSU’s unique, multifaceted approach to immunization lends itself to managing large and complex projects. With over three decades of providing extensive technical support to national and state governments in more than 55 countries, it draws upon its rich global experience to implement life-saving projects in India.
As one of India’s prime partners on Immunization, ITSU is supporting the Ministry of Health & Family Welfare (MoHFW) to strengthen routine immunization (RI) programs in rural and urban areas in ways that ensure all women and children have access to routine immunization services.
Rolling-out new vaccines
ITSU supported MoHFW in the rapid scale-up of Rotavirus vaccine in 2019 across 25 states/UTs in just 100 days and pneumococcal conjugate vaccine (PCV) in 31 states/UTs in 6 months in 2021. Following a cascade training model, it conducted national and state level training of trainers (ToT), district trainings and trainings of frontline workers. Innovative training solutions using a mix of online, offline and hybrid mode have been conducted foe PCV roll-out amidst the COVID-19 pandemic.
On October 29, 2021, Government of India launched the nationwide expansion of PCV under the Universal Immunization Programme (UIP). As the lead technical partner, ITSU is providing technical support to national and state governments to ensure smooth PCV implementation within planned timelines, as well as integrating the vaccine into the country’s RI programme while building capacity for its introduction in 14 states.
- Introducing the ‘My Village My Home’ project to engage communities in identifying and tracking all newborns to reduce left-outs and drop-outs.
- Providing technical support to MoHFW in developing many nationally-used learning modules and job aids for health workers.
- Monitoring Mission Indradhanush as well as new vaccine introductions such as Measles Rubella Vaccination campaigns.